C6orf141 and neoplasm: Our results reveal a significantly lower C6orf141 expression level along with advanced pathological stage (I vs II + III + IV, P < 0.001) and large tumor size (T1 vs T2 + 3 + 4, P < 0.005) in BMSCC, but not in TSCC (Table 4).